Produce Rx in High Risk Pregnant Mothers at Harris Health
Sponsored by The University of Texas Health Science Center, Houston
About this study
The purpose of this study is to assess the effectiveness of a "Food is Medicine" (FIM) intervention on incidence of gestational diabetes mellitus (GDM) among pregnant women at risk for GDM within the Harris Health system.
Where this study is enrolling
- I'm interested
The University of Texas Health Science Center at Houston
Houston, Texas
Who can participate
Inclusion criteria
- ✓pregnant women receiving care at Harris Health clinics
- ✓Medicaid eligible or receiving Medicaid
- ✓\<=14 weeks gestation at the time of the first prenatal visit and study enrollment
- ✓meet the ACOG criteria for early screening for GDM (have a BMI of 30 or greater and at least one additional ACOG-designated risk factor for GDM from the following: Age \> 35 years; Black, Hispanic, Native American, Asian American or Pacific Islander ethnicity; history of GDM in prior pregnancy; A1c level \> 5.7 \& \< 6.4; history of hypertension, pregnancy hypertension, heart disease, HIV, high triglycerides, polycystic ovarian syndrome; Immediate family member (parent or sibling) has had diabetes)
- ✓fall within the study delivery radius
Exclusion criteria
- ✕report existing or pregestational T2DM
- ✕have hemoglobin A1c\>=7
- ✕are prescribed insulin therapy or metformin upon first screening
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.